| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.0M | -23.7% | +18.5% |
| R&D Expense | $8.1M | -22.7% | -12.5% |
| SG&A Expense | $18.3M | -0.5% | +8.6% |
| Operating Income | -$6.5M | -136.9% | +40.4% |
| Pre-tax Income | -$2.9M | -103.9% | +71.3% |
| Income Tax | -$6.5M | -135.4% | -345.8% |
| Net Income | $3.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $174.8M | -38.0% | +647.6% |
| Current Assets | $354.7M | -3.2% | +204.5% |
| Total Assets | $415.5M | -2.5% | +16.7% |
| Current Liabilities | $37.4M | -31.5% | +59.6% |
| Stockholders' Equity | $232.7M | +3.5% | +25.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $244.6M | — | — |
| Investing Cash Flow | -$105.9M | — | — |
| Financing Cash Flow | -$1.8M | — | — |
| -93.4% |
| +128.5% |
| EPS (Basic) | $0.07 | -93.6% | +126.9% |
| EPS (Diluted) | $0.07 | -93.5% | +126.9% |